Beyond Achondroplasia

Growing together with Clara

June 3, 2017
by inesp.alves
1 Comment

BioMarin updates the Multicenter and Multinational Clinical Study 111-901

The “Multicenter, Multinational Clinical Assessment Study for Pediatric Patients With Achondroplasia” is a prospective observational study. This study’s code name is 111-901. The aim of this study is to collect systematic growth measurements of the children in order to collect data … Continue reading

February 12, 2014
by inesp.alves

A Phase 2 Study of BMN 111 to Evaluate Safety, Tolerability, and Efficacy in Children With Achondroplasia (ACH)

BioMarin activated now the Phase 2 study in the Another step forward! Only Chicago hospital is recruiting for now.  BMN 111 is being administered by a subcutaneous Injection and as a morning dose in one of the following daily dosing regimens: … Continue reading

Translate »